Table 1.

Phase I study evaluations including erythema and edema, skin atrophy, telangiectasia, and hypopigmentation

Scoring	Erythema and swelling	Atrophy	Telangiectasia	Hypopigmentation
0	No reaction	No atrophy	No telangiectasia	No hypopigmentation
1	Mild erythema, no edema	Mild atrophy	Mild telangiectasia	Mild hypopigmentation
2	Marked erythema and mild edema	Moderate atrophy	Moderate telangiectasia	Moderate hypopigmentation
3	Marked erythema, edema and vesicle	Marked atrophy	Marked telangiectasia	Marked hypopigmentation